Skeletal Muscle-Directed FGF21 Gene Therapy Counteracts Obesity and Type 2 Diabetes

被引:0
|
作者
Bosch, Fatima [1 ,2 ,3 ]
Jambrina, Claudia [1 ,2 ,3 ]
Sacristan, Victor [1 ,2 ,3 ]
Casana, Estefania [1 ,2 ,3 ]
Munoz, Sergio [1 ,2 ,3 ]
Rodo, Jordi [1 ,2 ,3 ]
Darriba, Sara [1 ,2 ,3 ]
Garcia, Miquel [1 ,2 ,3 ]
Leon, Xavier [1 ,2 ,3 ]
Grass, Ignasi [1 ,2 ,3 ]
Jimenez, Veronica [1 ,2 ,3 ]
机构
[1] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Bellaterra, Spain
[2] Univ Autonoma Barcelona, Sch Vet Med, Bellaterra, Spain
[3] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
796
引用
收藏
页码:369 / 369
页数:1
相关论文
共 50 条
  • [1] Skeletal muscle-directed FGF21 gene therapy counteracts obesity and type 2 diabetes
    Jambrina, C.
    Sacristan, V.
    Casana, E.
    Munoz, S.
    Rodo, J.
    Vila, L.
    Garcia, M.
    Leon, X.
    Grass, I.
    Jimenez, V.
    Bosch, F.
    HUMAN GENE THERAPY, 2019, 30 (11) : A152 - A152
  • [2] Reversion of Non-Alcoholic Steatohepatitis by Skeletal Muscle-Directed FGF21 Gene Therapy
    Jimenez, Veronica
    Sacristan, Victor
    Jambrina, Claudia
    Luisa Jaen, Maria
    Casana, Estefania
    Munoz, Sergio
    Garcia, Miquel
    Grass, Ignasi
    Leon, Xavier
    Elias, Ivet
    Ribera, Albert
    Elias, Gemma
    Sanchez, Victor
    Casellas, Alba
    Ferre, Tura
    Molas, Maria
    Bosch, Fatima
    MOLECULAR THERAPY, 2023, 31 (04) : 549 - 549
  • [3] Reversion of metabolic dysfunction-associated steatohepatitis by skeletal muscle-directed FGF21 gene therapy
    Jimenez, Veronica
    Sacristan, Victor
    Jambrina, Claudia
    Jaen, Maria Luisa
    Casana, Estefania
    Munoz, Sergio
    Marco, Sara
    Molas, Maria
    Garcia, Miquel
    Grass, Ignasi
    Leon, Xavier
    Elias, Ivet
    Ribera, Albert
    Elias, Gemma
    Sanchez, Victor
    Vila, Laia
    Casellas, Alba
    Ferre, Tura
    Rodo, Jordi
    Carretero, Ana
    Pumarola, Marti
    Navarro, Marc
    Andaluz, Anna
    Moll, Xavier
    Anor, Sonia
    Franckhauser, Sylvie
    Vergara, Mercedes
    Caixas, Assumpta
    Bosch, Fatima
    MOLECULAR THERAPY, 2024, 32 (12) : 4285 - 4302
  • [4] Reversion of Nonalcoholic Steatohepatitis by Skeletal-Muscle Directed FGF21 Gene Therapy
    Jimenez, Veronica
    Sacristan, Victor
    Jambrina, Claudia
    Jaen, Maria Luisa
    Munoz, Sergio A.
    Casana, Estefania
    Garcia, Miquel
    Grass, Ignasi
    Leon, Xavier
    Elias, Ivet
    Ribera, Albert
    Elias, Gemma
    Sanchez, Victor
    Casellas, Alba
    Ferre, Tura
    Molas, Maria
    Bosch, Fatima
    DIABETES, 2023, 72
  • [5] Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity
    Mashili, Fredirick L.
    Austin, Reginald L.
    Deshmukh, Atul S.
    Fritz, Tomas
    Caidahl, Kenneth
    Bergdahl, Katrin
    Zierath, Juleen R.
    Chibalin, Alexander V.
    Moller, David E.
    Kharitonenkov, Alexei
    Krook, Anna
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (03) : 286 - 297
  • [6] Liver directed FGF21 gene therapy reverses obesity and insulin resistance
    Jambrina, C.
    Jimenez, V.
    Casana, E.
    Sacristan, V.
    Munoz, S.
    Darriba, S.
    Rodo, J.
    Garcia, M.
    Marco, S.
    Ribera, A.
    Elias, I.
    Casellas, A.
    Grass, I.
    Ruberte, J.
    Bosch, F.
    DIABETOLOGIA, 2018, 61 : S325 - S325
  • [7] FGF21 resistance relevant to insulin resistance in skeletal muscle of patients with type 2 diabetes
    Lee, M.
    Jeon, J.
    Ha, E.
    Choi, S. -E.
    Kim, T.
    Ahn, S. -Y.
    Han, S.
    Kim, H.
    Kim, D.
    Kang, Y.
    Lee, K. -W.
    DIABETOLOGIA, 2013, 56 : S36 - S36
  • [8] Muscle-directed gene therapy
    Jackie Barlow
    Nature Biotechnology, 2001, 19 (3) : 217 - 217
  • [9] Skeletal muscle-directed gene therapy: hijacking the fusogenic properties of muscle cells
    Buening, Hildegard
    Morgan, Michael
    Schambach, Axel
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [10] Skeletal muscle-directed gene therapy: hijacking the fusogenic properties of muscle cells
    Hildegard Büning
    Michael Morgan
    Axel Schambach
    Signal Transduction and Targeted Therapy, 8